CDK12 and prostate cancer: The mechanisms linking CDK12 inactivation to increased intratumoral T cell presence in advanced prostate cancer (18) and the development of preneoplastic lesions with lymphocytic infiltration in the murine prostate epithelium (14) have remained unclear.